Phase I/II dose-finding design for molecularly targeted agent: Plateau determination using adaptive randomization. (February 2018)
- Record Type:
- Journal Article
- Title:
- Phase I/II dose-finding design for molecularly targeted agent: Plateau determination using adaptive randomization. (February 2018)
- Main Title:
- Phase I/II dose-finding design for molecularly targeted agent: Plateau determination using adaptive randomization
- Authors:
- Riviere, Marie-Karelle
Yuan, Ying
Jourdan, Jacques-Henri
Dubois, Frédéric
Zohar, Sarah - Abstract:
- Conventionally, phase I dose-finding trials aim to determine the maximum tolerated dose of a new drug under the assumption that both toxicity and efficacy monotonically increase with the dose. This paradigm, however, is not suitable for some molecularly targeted agents, such as monoclonal antibodies, for which efficacy often increases initially with the dose and then plateaus. For molecularly targeted agents, the goal is to find the optimal dose, defined as the lowest safe dose that achieves the highest efficacy. We develop a Bayesian phase I/II dose-finding design to find the optimal dose. We employ a logistic model with a plateau parameter to capture the increasing-then-plateau feature of the dose–efficacy relationship. We take the weighted likelihood approach to accommodate for the case where efficacy is possibly late-onset. Based on observed data, we continuously update the posterior estimates of toxicity and efficacy probabilities and adaptively assign patients to the optimal dose. The simulation studies show that the proposed design has good operating characteristics. This method is going to be applied in more than two phase I clinical trials as no other method is available for this specific setting. We also provide an R package dfmta that can be downloaded from CRAN website.
- Is Part Of:
- Statistical methods in medical research. Volume 27:Number 2(2018)
- Journal:
- Statistical methods in medical research
- Issue:
- Volume 27:Number 2(2018)
- Issue Display:
- Volume 27, Issue 2 (2018)
- Year:
- 2018
- Volume:
- 27
- Issue:
- 2
- Issue Sort Value:
- 2018-0027-0002-0000
- Page Start:
- 466
- Page End:
- 479
- Publication Date:
- 2018-02
- Subjects:
- Dose-finding -- molecularly targeted agents -- oncology -- phase I -- phase II
Medicine -- Research -- Statistical methods -- Periodicals
Research -- Periodicals
Review Literature -- Periodicals
Statistics -- methods -- Periodicals
Médecine -- Recherche -- Méthodes statistiques -- Périodiques
610.727 - Journal URLs:
- http://smm.sagepub.com/ ↗
http://www.ingentaselect.com/rpsv/cw/arn/09622802/contp1.htm ↗
http://www.uk.sagepub.com/home.nav ↗
http://firstsearch.oclc.org ↗
http://firstsearch.oclc.org/journal=0962-2802;screen=info;ECOIP ↗ - DOI:
- 10.1177/0962280216631763 ↗
- Languages:
- English
- ISSNs:
- 0962-2802
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 8084.xml